Literature DB >> 8007773

Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration.

H H Bengele1, S Palmacci, J Rogers, C W Jung, J Crenshaw, L Josephson.   

Abstract

The ultrasmall superparamagnetic iron oxide colloid BMS 180549 can be found lymph nodes by either subcutaneous (SC) or intravenous (IV) injection. With an SC injection in the front extremities, the axillary and brachial nodes attain the highest accumulations of the agent. With an SC injection in the rear extremities, the popliteal, iliac, and axillary nodes attain highest accumulations of the agent. With IV injection of the agent, the iliac, mediastinal and mesenteric nodes attain highest accumulations of the agent. Though the spleen is not involved with the drainage of the interstitial space near the site of SC injections, the mobility of BMS 180549 from such injection sites increases splenic relaxation rates. Based on a knowledge of the lymphatic system, a route of administration of BMS 180549 can be chosen to maximize the delivery of the agent to specific lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8007773     DOI: 10.1016/0730-725x(94)92537-2

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  10 in total

1.  Evaluation of tumoral enhancement by superparamagnetic iron oxide particles: comparative studies with ferumoxtran and anionic iron oxide nanoparticles.

Authors:  P-Y Brillet; F Gazeau; A Luciani; B Bessoud; C-A Cuénod; N Siauve; J-N Pons; J Poupon; O Clément
Journal:  Eur Radiol       Date:  2005-02-23       Impact factor: 5.315

Review 2.  In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.

Authors:  Hamed Arami; Amit Khandhar; Denny Liggitt; Kannan M Krishnan
Journal:  Chem Soc Rev       Date:  2015-09-21       Impact factor: 54.564

3.  Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy.

Authors:  Kannan M Krishnan
Journal:  IEEE Trans Magn       Date:  2010-07-01       Impact factor: 1.700

4.  Magnetic Nanoclusters with Hydrophilic Spacing for Dual Drug Delivery and Sensitive Magnetic Resonance Imaging.

Authors:  Nipon Pothayee; Sharavanan Balasubramaniam; Nikorn Pothayee; Neeta Jain; Nan Hu; Yinnian Lin; Richey M Davis; Nammalwar Sriranganathan; Alan P Koretsky; J S Riffle
Journal:  J Mater Chem B       Date:  2013       Impact factor: 6.331

Review 5.  Contrast-enhanced MR imaging of lymph nodes in cancer patients.

Authors:  Seung Hong Choi; Woo Kyung Moon
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

6.  Noninvasive evaluation of cardiac allograft rejection by cellular and functional cardiac magnetic resonance.

Authors:  Yijen L Wu; Qing Ye; Kazuya Sato; Lesley M Foley; T Kevin Hitchens; Chien Ho
Journal:  JACC Cardiovasc Imaging       Date:  2009-06

7.  Chelate-free metal ion binding and heat-induced radiolabeling of iron oxide nanoparticles.

Authors:  Eszter Boros; Alice M Bowen; Lee Josephson; Neil Vasdev; Jason P Holland
Journal:  Chem Sci       Date:  2014-09-29       Impact factor: 9.825

8.  Real-time in vivo monitoring of magnetic nanoparticles in the bloodstream by AC biosusceptometry.

Authors:  André G Próspero; Caio C Quini; Andris F Bakuzis; Patrícia Fidelis-de-Oliveira; Gustavo M Moretto; Fábio P F Mello; Marcos F F Calabresi; Ronaldo V R Matos; Ednaldo A Zandoná; Nícholas Zufelato; Ricardo B Oliveira; José R A Miranda
Journal:  J Nanobiotechnology       Date:  2017-03-21       Impact factor: 10.435

9.  Stealth properties to improve therapeutic efficacy of drug nanocarriers.

Authors:  Stefano Salmaso; Paolo Caliceti
Journal:  J Drug Deliv       Date:  2013-03-07

Review 10.  Iron Oxide as an MRI Contrast Agent for Cell Tracking.

Authors:  Daniel J Korchinski; May Taha; Runze Yang; Nabeela Nathoo; Jeff F Dunn
Journal:  Magn Reson Insights       Date:  2015-10-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.